Sign in
4

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001864317-22-000007

Chief Financial Officer bought 10,000 shares at $1.11 ($11,092)

From the SEC's structured data for this filing

Trades in this filing

Katzoff David J · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-14 Purchase : show line 1 in the form +10,000 $1.11 $11,092 28,000 D
Open-market purchases · 10,000 sh · avg $1.11 · $11,092
Loading xslF345X03/primary_doc.xml…